NCT04447183 2023-10-23
DTC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Unknown
Clinical Trials
5 trialsNCT03707509 2022-07-01
Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT05075122 2022-03-09
FOCUS
Martin-Luther-Universität Halle-Wittenberg
Phase 2 Unknown
NCT04282070 2021-12-21
SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04015661 2019-07-11
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC
Fuzhou General Hospital
Phase 2 Unknown